Health

Biotech Industry Developments

Updated 2026-05-23 21:50 UTC 1 source Neutral

EU and US advisers are divided over AstraZeneca's breast cancer drug, while two closely watched biotech trials have yielded mixed results. Merck-Kelun's ADC outperformed Keytruda in a trial, but a Parkinson’s drug failed.

Coverage timeline — 2 articles

STAT News

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The Readout

2026-05-22 13:40 UTC

STAT News

STAT+: Stealth biotech Stipple bets on secretive ADCs

How thin science fuels peptide hype, blowback to proposed NIH cuts, and more biotech news from The Readout

2026-04-06 13:13 UTC